Brynne Coupland Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 344 Skyview Pl, Chuluota, FL 32766 Phone: 407-754-4398 |
News Archive
Protecting the wealth of older adults should be a high priority for banks, insurance companies, and others, according to the latest edition of Public Policy & Aging Report (PP&AR). Elder financial exploitation and diminished financial capacity resulting from age-related cognitive impairments both pose major economic threats, the issue finds.
NivaSonix, LLC announced today the allowance by the U. S. Patent and Trademark Office (USPTO) of its core patent "External Ultrasound Lipoplasty". Nine additional U.S. and international patents are pending with additional patent filings in progress. The patent describes a technology that allows a new generation of non-invasive ultrasound therapy for both fat and wrinkle reduction targeted for patients worldwide.
Cardiovascular disease is a major cause of death among homeless adults, with mortality rates that are substantially higher than the general population.
About one-third of all genes in the mammalian genome are essential for life. An international, multi-institutional research collaboration identified, for the first time, mutant traits in the mouse for 52 human disease genes, which significantly contributes to the understanding of the genetic bases for some human diseases, including cardiovascular defects, spina bifida, and metabolic disorders, among many others. The study was published this week in Nature.
Merrimack Pharmaceuticals, Inc., a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of serious diseases, with an initial focus on cancer, today announced the pricing of its initial public offering of 14,300,000 shares of its common stock at $7.00 per share, before underwriting discounts and commissions. All of the shares in the offering are being sold by Merrimack.
› Verified 1 days ago